Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

GPI-1485 shows neuroprotective activity in preclinical models of postprostatectomy ED

Oct. 1, 2002

Vardenafil: phase III clinical data discussed at congress, trade name selected

Sep. 27, 2002

Trospium meets endpoints in phase III overactive bladder trial

Sep. 25, 2002

Cozaar reduces the risk of ESRD in patients with type 2 diabetes, nephropathy and hypertension

Sep. 23, 2002

New option available for patients with hypertension and diabetic kidney disease

Sep. 20, 2002

Resiniferatoxin: safe and effective for neurogenic and idiopathic bladder overactivity

Sep. 19, 2002

European approval for Fosrenol delayed

Sep. 18, 2002

Research findings support use of KRP-197 for overactive bladder

Sep. 18, 2002

Sustained beneficial effects reported for tadalafil in men with ED

Sep. 18, 2002

Chinese research demonstrates efficacy and safety of epristeride for BPH

Sep. 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...